Adam Koppel's Net Worth

$3.28 Billion

Who is Adam Koppel?

Adam Koppel has an estimated net worth of $3.28 Billion. This is based on reported shares across multiple companies, which include BIOGEN INC., Dicerna Pharmaceuticals Inc, MARINUS PHARMACEUTICALS INC, RAPID MICRO BIOSYSTEMS, INC., Arcutis Biotherapeutics, Inc., Foghorn Therapeutics Inc., BCLS Acquisition Corp., SpringWorks Therapeutics, Inc., Replimune Group, Inc., Cerevel Therapeutics Holdings, Inc., PTC THERAPEUTICS, INC., TREVENA INC, Solid Biosciences Inc., Annexon, Inc., and Aptinyx Inc..

SEC CIK

Adam Koppel's CIK is 0001578965

Past Insider Trading and Trends

2020 was Adam Koppel's most active year for acquiring shares with 22 total transactions. Adam Koppel's most active month to acquire stocks was the month of May. 2021 was Adam Koppel's most active year for disposing of shares, totalling 14 transactions. Adam Koppel's most active month to dispose stocks was the month of November. 2023 saw Adam Koppel paying a total of $124,999,986.12 for 5,522,764 shares, this is the most they've acquired in one year. In 2021 Adam Koppel cashed out on 47,343,056 shares for a total of $291,871,552.50, their largest year based on trade value.